The Zacks Analyst Blog Highlights Exelon, Gilead Sciences, Plains All American Pipeline, Sportradar and Cintas

For Immediate ReleaseChicago, IL – March 12, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Exelon Corp. EXC, Gilead Sciences Inc. GILD, Plains All American Pipeline L.P. PAA , Sportradar Group AG SRAD and Cintas Corp. CTAS.Here are highlights from Tuesday’s Analyst Blog:Buy 5 Non-Tech High-Flying Nasdaq Stocks Amid Index's Recent BloodbathWall Street's high-flying northward journey from January 2023 to January 2025 was predominantly supported by an astonishing rally in the technology sector, buoyed by the explosive growth of generative artificial intelligence (AI). Several AI-centric stocks skyrocketed 400-500% during this period.As many financial experts and economists expect a near-term recession, investors are gradually booking profits in tech stocks, for which valuations are extremely overstretched. The three major stock indexes — the Dow, the S&P 500 and the Nasdaq Composite — are in negative territory year to date.The Nasdaq Composite is currently in correction territory, sliding 14% from its recent high. The S&P 500 is also 8.7% below its recent high. An index enters correction territory once it falls below 10% of its recent high. Despite the index's recent bloodbath, a handful of non-tech Nasdaq Composite listed stocks have provided double-digit returns year to date. At this juncture, investing in these stocks should prove fruitful.Five such stocks with a favorable Zacks Rank are Exelon Corp., Gilead Sciences Inc., Plains All American Pipeline L.P., Sportradar Group AG and Cintas Corp..Recession Fear Looms LargeWall Street's impressive bull run that started at the beginning of 2023 suffered a blow last month. Thereafter, market participants' pain has increased manifold. Investors are highly anxious about the impact of the Trump administration's tariff and trade policies.Recently released several key economic data have clearly shown that the U.S. economy is weakening. The resilient labor market has shown softness. Last released data for retail sales, industrial production, manufacturing PMI, housing sector data as well as consumer confidence and sentiment indexes came in well below expectations.Market participants are now highly skeptical about the Fed's much-hyped "soft landing" of the U.S. economy. The Fed reduced the benchmark lending rate by a significant 1% in 2024. However, Chairman Jerome Powell said the central bank is in no hurry to cut rates further any time soon.According to Powell, "the time and magnitude of the rate cut will depend on inflation and other key economic data. In addition, this time the rate cut decision will be guided by the Trump administration's tariffs and trade related policies." Importantly, in an interview last weekend, President Donald Trump did not rule out of the possibility of a near-term recession in the U.S. economy.5 Non-Tech Nasdaq Stocks to BuyWe have narrowed our search to five Nasdaq Composite-listed non-tech stocks that have provided double-digit returns year to date. These stocks have strong growth potential for 2025 and have seen positive earnings estimate revisions in the past 60 days. Each of our picks carries a Zacks Rank #2 (Buy). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.Exelon Corp.Exelon's investment will strengthen its transmission and distribution infrastructure and assist in providing reliable services to customers. EXC's initiatives in grid modernization will improve the resilience of its operations, and revenue decoupling will mitigate the impact of load fluctuation. A stable cash flow allows EXC to pay regular dividends. The development of data centers will increase demand.Exelon has an expected revenue and earnings growth rate of 3.4% and 5.6%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved 0.4% over the past seven days. EXC has a current dividend yield of 3.71%.Exelon is currently trading at an attractive valuation compared to its peers. The stock has forward price/earnings (P/E) of 16.32X, below the industry's P/E of 17.95X and the S&P 500's P/E of 18.58X. It has a price/sale (P/S) of 1.88X, compared with the industry's P/S of 2.22X and the S&P 500's P/S of 2.91X. Moreover, it has a price/book (P/B) of 1.61X, compared with the industry's P/B of 1.51X and the S&P 500's P/B of 3.53X.Gilead Sciences Inc.Gilead Sciences reported better-than-expected fourth-quarter results and provided an upbeat guidance for 2025. GILD's flagship HIV therapy, Biktarvy, continues to maintain its strong growth, fueling the top line. GILD's efforts to develop better HIV treatments are commendable. Recent data validate lenacapavir's potential to prevent HIV.A potential approval of lenacapavir should be a significant boost for Gilead. Our sales estimates for Biktarvy indicate a CAGR of around 4.5% over the next three years. GILD's efforts to bolster its oncology and virology franchises through internal pipeline development and collaborations are impressive as well.Gilead Sciences has an expected revenue and earnings growth rate of -0.7% and 70.4%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved 0.1% over the past seven days. GILD has a current dividend yield of 2.62%.Gilead Sciences is currently trading at an impressive valuation. The stock has forward P/E of 14.92X, below the industry's P/E of 19.23X and the S&P 500's P/E of 18.58X. It has a P/S of 5.09X, compared with the industry's P/S of 5.73X and the S&P 500's P/S of 2.91X. Moreover, GILD currently has a return on Equity (ROE) of 31.63%, compared with the industry's ROE of -62.66% and the S&P 500's ROE of 17.11%.Plains All American Pipeline L.P.Plains All American Pipeline Plains All American Pipelines' widespread Permian Basin operations should allow it to capture the increasing Permian production volumes. PAA's cost-saving initiatives, joint venture and asset divestitures are expected to boost operations.PAA's expansion of existing pipelines and development of new pipeline projects in key production regions of the United States should drive its operations. PAA has enough liquidity to meet its near-term debt obligations.Plains All American Pipeline has an expected revenue and earnings growth rate of 2.7% and 1.3%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved 2% over the past 30 days. PAA has a current dividend yield of 7.86%.Plains All American Pipeline is currently trading at a solid valuation. The stock has forward P/E of 12.66X, compared with the industry's P/E of 11.98X and the S&P 500's P/E of 18.58X. It has a P/S of 0.27X, compared with the industry's P/S of 1.12X and the S&P 500's P/S of 2.91X. Moreover, It has a P/B of 1.26X, compared with the industry's P/B of 1.42X and the S&P 500's P/B of 3.53X.Sportradar Group AGSportradar Group provides sports data services for the sports betting and media industries in the United Kingdom, the United States, Malta, Switzerland, and internationally. SRAD offers sports data services to the bookmaking under the Betradar brand name, and to the international media industry under the Sportradar Media Services brand name. SRAD offers mission-critical software, data, and content to sports leagues and federations, betting operators, and media companies.SRAD also provides sports entertainment, gaming, and sports solutions, as well as live streaming solutions for online, mobile, and retail sports betting. In addition, SRAD's software solutions address the entire sports betting value chain from traffic generation and advertising technology to the collection, processing, and extrapolation of data and odds, as well as to visualization solutions, risk management and platform services.Sportradar Group has an expected revenue and earnings growth rate of 15.7% and 94.7%, respectively, for the current year. The Zacks Consensus Estimate for current-year earnings has improved 1.2% over the past 60 days.Cintas Corp.Cintas is well-positioned to benefit from the solid momentum across its segments. Penetration of additional products and services into existing customers is aiding CTAS' Uniform Rental and Facility Services segment.Improved demand for AED Rentals and WaterBreak products is driving CTAS' First Aid and Safety Services segment. CTAS' investments in technology and automation hold promise. The successive acquisitions of Paris Uniform and SITEX sparked optimism in the stock. Also, handsome rewards to its shareholders add to CTAS' appeal.Cintas has an expected revenue and earnings growth rate of 7.3% and 13.7%, respectively, for the current year (ending May 2025). The Zacks Consensus Estimate for current-year earnings has improved 1.9% over the past 60 days. Cintas has a current dividend yield of 0.77%. Moreover, CTAS currently has a ROE of 40.62%, compared with the industry's ROE of 12.02% and the S&P 500's ROE of 17.11%.Why Haven't You Looked at Zacks' Top Stocks?Since 2000, our top stock-picking strategies have blown away the S&P's +7.7% average gain per year. Amazingly, they soared with average gains of +48.4%, +50.2% and +56.7% per year.Today you can access their live picks without cost or obligation.See Stocks Free >>Media ContactZacks Investment Research800-767-3771 ext. 9339support@zacks.com                                      https://www.zacks.com                                                   Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Exelon Corporation (EXC): Free Stock Analysis Report Plains All American Pipeline, L.P. (PAA): Free Stock Analysis Report Gilead Sciences, Inc. (GILD): Free Stock Analysis Report Cintas Corporation (CTAS): Free Stock Analysis Report Sportradar Group AG (SRAD): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks